A rare condition that presents with refractory and many times super-refractory status epilepticus, NORSE, including its subtype febrile infection related epilepsy syndrome (FIRES), is heterogeneous ...
RADNOR, Pa.--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today presented ...
A rare and nevertheless formidable event in the landscape of epilepsies, New-Onset Refractory Status Epilepticus (NORSE) is a form of prolonged seizure in which the neurons of the epileptic focus ...
RADNOR, Pa.--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced ...
Please provide your email address to receive an email when new articles are posted on . Status epilepticus incurred “a large burden” on patients and the U.S. health care system over a 3-year study of ...
Although the condition is rare and cases are limited, researchers were able to generally conclude vagal nerve stimulation (VNS) serves as a well-tolerated intervention. In a recent perspective piece, ...
Sustained, intensive therapy with two antiglutamatergic drugs is superior to standard aggressive treatment for postanoxic super-refractory status epilepticus (SRSE), new research suggests. In a ...
Investors anxious to see data from Marinus Pharmaceuticals Inc.’s phase III Raise study testing intravenous ganaxolone in refractory status epilepticus (RSE) will have to wait a little longer, as the ...
Editor's Note: This post originally appeared on Cleveland Clinic’s ConsultQD Blog. This patient's neurologic symptoms dated back to age 5 years, when her parents say she began experiencing memory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results